463 results match your criteria Tinea Cruris


Chronic Eczema Developing Over Skin Treated for Dermatophytosis in Atopic Patients -Importance of Treating Gently and Intelligently.

Indian J Dermatol 2022 Jan-Feb;67(1):93

Department of Dermatology, Bhojani Clinic, Babasaheb Ambedkar Road, Matunga, Mumbai, Maharashtra, India.

A novel observation of chronic eczema developing over the skin of adequately treated lesions of tinea cruris/tinea corporis in six atopic individuals is being shared. We propose that the skin of atopic individuals affected by dermatophytosis be observed for secondary changes even after the complete resolution of the lesions. The use of bland emollients with topical antifungal agents should be encouraged in atopic patients. Read More

View Article and Full-Text PDF

Evaluating diagnostic utility of PAS stained skin scrape cytology smear in clinically suspected superficial cutaneous mycoses: A simple yet unpracticed technique.

J Family Med Prim Care 2022 Mar 10;11(3):1089-1094. Epub 2022 Mar 10.

Department of Pathology, Peoples' College of Medical Sciences and Research Centre (PCMS&RC), India.

Background And Objectives: For fungal dermatitis, a wet Potassium Hydroxide (KOH) preparation of the skin scrapings forms the routine practice for diagnosis. This study was carried out to determine the diagnostic accuracy and to evaluate the value-added information of PAS-stained scrape cytology smear in evaluating the presence of fungal elements.

Methods: This prospective study was carried out on the patients clinically diagnosed with superficial cutaneous mycoses. Read More

View Article and Full-Text PDF

Changing face of epidemiology of dermatophytoses in Chinese Mainland: A 30 years nationwide retrospective study from 1991 to 2020.

Mycoses 2022 Apr 10;65(4):440-448. Epub 2022 Feb 10.

Department of Medical Mycology, Institute of Dermatology, Chinese Academy of Medical Science and Peking Union Medical College, Nanjing, China.

Background: Dermatophytoses are the most common infectious skin disease. Its epidemiology varies in different countries and regions, and its prevalence in China is still unknown.

Objectives: We aimed to reveal the epidemiological features of dermatophytoses in Chinese mainland in the past thirty years. Read More

View Article and Full-Text PDF

Efficacy and Safety of Eberconazole vs Sertaconazole in Localised Tinea Infection.

Indian J Dermatol 2021 Sep-Oct;66(5):573

Department of Dermatology, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth University, Pondicherry, Tamil Nadu, India.

Background: Topical antifungals especially azole group of drugs are effective agents in the treatment of dermatophytoses producing 100% clinical and mycological cure. Each of them vary having specific characteristics to tackle several clinical challenges like high relapse rate, recurrences and quality of life.

Aims And Objectives: To compare the efficacy and safety of Eberconazole and Sertaconazole in infection. Read More

View Article and Full-Text PDF
January 2022

Oral Isotretinoin Combined with Oral Terbinafine Versus Oral Terbinafine Alone to Treat Recurrent Dermatophytosis: An Open-Label Randomised Clinical Trial.

Indian Dermatol Online J 2021 Nov-Dec;12(6):820-825. Epub 2021 Nov 22.

Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India.

Background: Recurrent dermatophytosis is becoming arduous to treat. Recently, oral itraconazole with oral isotretinoin was successful in a patient suffering from recurrent dermatophytosis.

Objectives: To evaluate if oral isotretinoin confers any added benefit over oral terbinafine in the treatment of recurrent dermatophytosis. Read More

View Article and Full-Text PDF
November 2021

A Case of Terbinafine-Resistant Tinea Cruris Caused by .

Case Rep Dermatol Med 2021 29;2021:9611072. Epub 2021 Nov 29.

Department of Microbial Biotechnology, Islamic Azad University, Damghan, Iran.

A 26-year-old male patient referred to our center with a history of extremely itchy crusted skin lesions in his groins for one year. Moreover, his friend, a 25-year-old male, also developed similar lesions in the groin after using the shared pool, whose condition also did not improve with similar treatment. A regular mycology test (direct and culture test) was performed, as well as molecular examination. Read More

View Article and Full-Text PDF
November 2021

Comparison of efficacy, safety, and cost-effectiveness of sertaconazole and luliconazole cream in patients with dermatophytoses: A prospective, randomized, open-label study.

Perspect Clin Res 2021 Oct-Dec;12(4):223-228. Epub 2021 Jan 8.

Department of Pharmacology, Government Medical College, Nagpur, Maharashtra, India.

Objective: To compare efficacy, safety, and cost-effectiveness of sertaconazole (2%) and luliconazole (1%) cream in patients with dermatophytoses.

Materials And Methods: Sixty-four patients with tinea corporis and tinea cruris infections were enrolled in this single-center, randomized, open-label, parallel study. Following inclusion and exclusion criteria, patients were randomly divided into two treatment groups and received either sertaconazole 2% cream applied topically twice daily for 4 weeks and luliconazole 1% cream once daily for 2 weeks. Read More

View Article and Full-Text PDF
January 2021

Clinico-Mycological Profile of Treatment-Naïve, Chronic, Recurrent and Steroid-Modified Dermatophytosis at a Tertiary Care Centre in Eastern India: An Institution-Based Cross-SectionalStudy.

Indian Dermatol Online J 2021 Sep-Oct;12(5):714-721. Epub 2021 Sep 10.

Department of Microbiology, College of Medicine and SagoreDutta Hospital, Kolkata- 700 058, West Bengal, India.

Background: Dermatophytosis has recently emerged as a major public health problem in the Indian subcontinent, most cases becoming chronic and recurrent.

Aims: Assessing the clinico-epidemiologic and mycologic profile of treatment naïve, chronic, recurrent and steroid-modified dermatophytosis.

Materials And Methods: We conducted across-sectional study involving 111 cases of dermatophytosis. Read More

View Article and Full-Text PDF
September 2021

Real World Analysis of Response Rate and Efficacy of Oral Ketoconazole in Patients with Recalcitrant Tinea Corporis and Cruris.

Am J Trop Med Hyg 2021 10 11;106(1):38-44. Epub 2021 Oct 11.

Community Medicine, Dr. RML Hospital & PGIMER, New Delhi, India.

Recalcitrant dermatophytosis has had an alarming rise in India with concomitant decreased effectiveness of conventional antifungal agents. This has prompted the use of second-line agents for treatment. In this retrospective study, we aimed to analyze the response rate, efficacy, relapse rate, and side effects of oral ketoconazole (KZ) in the treatment of recalcitrant tinea corporis and cruris. Read More

View Article and Full-Text PDF
October 2021

Pyogenic granuloma-like lesions due to antifungal-corticosteroid combination creams.

Authors:
V Ramesh

Indian J Dermatol Venereol Leprol 2021 Nov-Dec;87(6):854-855

Department of Dermatology & STD, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.

View Article and Full-Text PDF
February 2022

An Open-Label, Randomized, Double-Arm Clinical Trial to Compare the Effectiveness and Safety of Super Bioavailable Itraconazole Capsules and Itraconazole Capsules in the Management of Dermatophytosis in India.

Clin Cosmet Investig Dermatol 2021 27;14:1367-1376. Epub 2021 Sep 27.

Global Medical Affairs, Glenmark Pharmaceuticals Ltd, Mumbai, Maharashtra, India.

Purpose: A new oral formulation of itraconazole, called super bioavailable itraconazole (SBITZ), has been launched in India, exhibiting greater bioavailability than conventional itraconazole (CITZ). No clinical studies on its effectiveness and safety in dermatophytosis in comparison with CITZ have been conducted in India. Hence, the aim of this clinical study was to compare the effectiveness and safety of SBITZ capsules and CITZ capsules in dermatophytosis. Read More

View Article and Full-Text PDF
September 2021

Predicting a therapeutic cut-off serum level of itraconazole in recalcitrant tinea corporis and cruris-A prospective trial.

Mycoses 2021 Dec 9;64(12):1480-1488. Epub 2021 Oct 9.

Medical Mycology Unit, Department of Microbiology, Vallabhbhai Patel Chest Institute, University of Delhi, New Delhi, India.

Background: With rising resistance to terbinafine, and consistently high MICs to fluconazole and griseofulvin, itraconazole is being increasingly used as a first line drug for tinea corporis/cruris. However, inadequate clinical responses are often seen with it in spite of in vitro susceptibility. This is possibly related to a variable pharmacokinetic profile of itraconazole. Read More

View Article and Full-Text PDF
December 2021

Comparison of Success Rate and Complications of Totally Percutaneous Decannulation in Patients With Veno-Arterial Extracorporeal Membrane Oxygenation and Endovascular Aneurysm Repair.

Front Med (Lausanne) 2021 20;8:724427. Epub 2021 Aug 20.

Department of Vascular Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.

Total percutaneous closure for the site of femoral arterial puncture using Perclose ProGlide (PP) has become prevalent post-percutaneous endovascular aortic repair (EVAR) and veno-arterial extracorporeal membrane oxygenation (VA-ECMO). To evaluate the safety and efficacy of total percutaneous closure of the femoral artery access site post-EVAR compared with VA-ECMO. This was a retrospective observational study conducted over 4 years, including 88 patients who underwent EVAR (64 patients) and VA-ECMO (24 patients). Read More

View Article and Full-Text PDF

The influence of superficial dermatophytoses epidemic in India on patients' quality of life.

Postepy Dermatol Alergol 2021 Feb 27;38(2):102-105. Epub 2019 Nov 27.

Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland.

Introduction: Superficial dermatophytoses constitute a common and growing problem in India. However, the associated impact on the affected individuals' quality of life (QoL) has rarely been investigated.

Aim: To assess the quality of life of patients with different dermatophytoses. Read More

View Article and Full-Text PDF
February 2021

A multicentric clinical and epidemiological study of chronic and recurrent dermatophytosis in India.

Mycoses 2022 Jan 19;65(1):13-23. Epub 2021 Aug 19.

Department of Dermatology, Dr R. P. Govt. Medical College, Tanda, India.

Background: There has been an alarming increase in the prevalence of chronic, recurrent and steroid modified dermatophytosis of the glabrous skin in the recent years in India. There is paucity of literature on the magnitude of this major public health problem.

Objective: To estimate the prevalence of dermatophytosis and clinico-epidemiological features of chronic and recurrent dermatophytosis (CRD) across India and to evaluate the associated risk factors. Read More

View Article and Full-Text PDF
January 2022

[Treatment of a terbinafine-resistant trichophyton mentagrophytes type VIII].

Hautarzt 2021 Oct 9;72(10):900-904. Epub 2021 Jul 9.

Universitätshautklinik Tübingen, Liebermeisterstr. 25, 72076, Tübingen, Deutschland.

This article reports on a patient suffering from terbinafine-resistant tinea corporis acquired in Asia. Trichophyton mentagrophytes type VIII was first isolated in India. In the past few years, it has gained clinical relevance by causing terbinafine-resistant tinea corporis and cruris. Read More

View Article and Full-Text PDF
October 2021

Etiological prevalence and antifungal sensitivity patterns of dermatophytosis in India - A multicentric study.

Indian J Dermatol Venereol Leprol 2021 Nov-Dec;87(6):800-806

Calcutta Skin Institute, 169, Scheme 6 M, C I T Road, Kankurgachi, Kolkata, West Bengal, India.

Background: The prevalence of dermatophytes varies with season, geographical area, socio-economic factors and effective management strategies.

Aims: The aim of the study was to assess the prevalence of pathogenic dermatophytes, clinical types of dermatophyte fungal infection, and in vitro antifungal drug susceptibility testing against dermatophytes.

Methods: Three hundred and ninety five patients with dermatophytosis were enrolled from five cities (Mumbai, Delhi, Lucknow, Kolkata and Hyderabad) across India. Read More

View Article and Full-Text PDF
February 2022

Checkerboard Analysis To Evaluate Synergistic Combinations of Existing Antifungal Drugs and Propylene Glycol Monocaprylate in Isolates from Recalcitrant Tinea Corporis and Cruris Patients Harboring Squalene Epoxidase Gene Mutation.

Antimicrob Agents Chemother 2021 07 16;65(8):e0032121. Epub 2021 Jul 16.

Vyome Therapeutics Limited, New Delhi, India.

Recalcitrant dermatophytic infections of the glabrous skin (tinea corporis/cruris/faciei) pose a huge challenge to health care systems. Combinations of oral and topical drugs may potentially improve cure rates, but the same has never been objectively assessed for this condition in laboratory or clinical studies. The present study was undertaken with the aim of identifying synergistic combinations of oral and topical antifungals by testing clinical isolates obtained from patients with recalcitrant tinea corporis/cruris. Read More

View Article and Full-Text PDF

Prevalence of superficial-cutaneous fungal infections in Shiraz, Iran: A five-year retrospective study (2015-2019).

J Clin Lab Anal 2021 Jul 24;35(7):e23850. Epub 2021 May 24.

Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Background: Superficial and cutaneous fungal infections are common in tropical areas. The aim of this study was to provide a basic database of superficial and cutaneous mycoses and the most common etiological agents among patients.

Methods: Between 2015 and 2019, a total of 1807 patients suspected of superficial and cutaneous mycosis referring to the mycology laboratory of Shiraz medical school, Fars, Iran were evaluated. Read More

View Article and Full-Text PDF

Iatrogenic Cushing's Syndrome in Patients with Superficial Dermatophytosis.

Indian Dermatol Online J 2021 Mar-Apr;12(2):237-243. Epub 2021 Mar 2.

Department of Endocrinology and Metabolism University College of Medical Sciences and GTB Hospital (University of Delhi), Delhi, India.

Background: The epidemic-like scenario of superficial fungal infections in India has been complicated by the prescription of systemic and topical potent steroids. As a result, alarming number of patients are presenting with exogenous Cushing's syndrome.

Methods: This cross-sectional study involved 23 patients of superficial dermatophytosis on steroids who presented with clinical features like that of Cushing's syndrome. Read More

View Article and Full-Text PDF

Secondary syphilis mimicking tinea cruris in an HIV infected patient: a case report.

Pan Afr Med J 2021 5;38:133. Epub 2021 Feb 5.

Department of Dermatology and Venereology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia.

Syphilis is known as the great imitator with various clinical presentations which often lead to confusion and misdiagnosis. A 28-year-old male presented with non-pruritic and painless erythematous patches around the anus and scrotum. Initial differential diagnosis with tinea cruris. Read More

View Article and Full-Text PDF

The unprecedented epidemic-like scenario of dermatophytosis in India: I. Epidemiology, risk factors and clinical features.

Indian J Dermatol Venereol Leprol 2021 Mar-Apr;87(2):154-175

Bhojani Clinic, Mumbai, Maharashtra, India.

Dermatophytosis has attained unprecedented dimensions in recent years in India. Its clinical presentation is now multifarious, often with atypical morphology, severe forms and unusually extensive disease in all age groups. We hesitate to call it an epidemic owing to the lack of population-based prevalence surveys. Read More

View Article and Full-Text PDF
November 2021

Clear zone phenomenon: A rare phenomenon in ichthyosis with co-existing superficial fungal infection.

Indian J Dermatol Venereol Leprol 2021 Jan-Feb;87(1):103-105

Department of Dermatology and STD, Lady Hardinge Medical College and SSKH, KSCH, Delhi - 110001, India.

View Article and Full-Text PDF
November 2021

Epidemiological study of terbinafine-resistant dermatophytes isolated from Japanese patients.

J Dermatol 2021 Apr 13;48(4):564-567. Epub 2021 Jan 13.

Department of Veterinary Dermatology, Nihon University College of Bioresource Sciences, Fujisawa, Kanagawa, Japan.

Terbinafine (TRF) has been used in the treatment of fungal infections for more than 20 years. Recently, TRF-resistant Trichophyton interdigitale and T. rubrum strains have been isolated from human patients worldwide. Read More

View Article and Full-Text PDF

Terbinafine resistance in dermatophytes: Time to revisit alternate antifungal therapy.

J Mycol Med 2021 Mar 19;31(1):101087. Epub 2020 Nov 19.

Department of Microbiology, University College of Medical Sciences, Delhi 110095, India. Electronic address:

Resistant superficial dermatophytic infections of the skin and its appendages have emerged as a major health problem in India. Mutations in Squalene epoxidase gene have led to increasing incidence of resistance to terbinafine in dermatophytic isolates. We examined six patients with recalcitrant dermatophytosis attending Dermatology OPD at a tertiary care hospital and demonstrated terbinafine resistance by molecular method. Read More

View Article and Full-Text PDF

Topical clotrimazole cream for the treatment of tinea cruris: A retrospective study.

Medicine (Baltimore) 2020 Nov;99(47):e23189

Department of Dermatology.

This retrospective study assessed the efficacy and safety of 1% topical clotrimazole cream for the treatment of patients with tinea cruris (TC).We included 86 patients with confirmed TC for the presence of fungal hyphae. Of those, 43 patients received 1% topical clotrimazole cream for a total of 4 consecutive weeks, and were assigned to an experimental group. Read More

View Article and Full-Text PDF
November 2020

Analysis on the pathogenic fungi in patients with superficial mycosis in the Northeastern China during 10 years.

Exp Ther Med 2020 Dec 27;20(6):281. Epub 2020 Oct 27.

Department of Dermatology, The First Affiliated Hospital of Qiqihar Medical University, Qiqihar, Heilongjiang 161041, P.R. China.

This study analyzed the infection of superficial mycosis and the relationship between the distribution characteristics of pathogenic fungi and age, time and sex in Northeast China in the past 10 years. We would like to provide a theoretical basis for the diagnosis and treatment of related diseases. From December 2008 to December 2018, 5,374 superficial mycoses from Northeast China were selected. Read More

View Article and Full-Text PDF
December 2020

Dermatophytosis caused by Nannizzia nana.

J Mycol Med 2021 Jun 6;31(2):101047. Epub 2020 Oct 6.

Psychodermatology task force of the Ibero-Latin American College of Dermatology (CILAD), Buenos Aires, Argentina; European Women's Dermatologic and Venereologic Society (EWDVS), Tui, Spain; Efficiency, Quality, and Costs in Health Services Research Group (EFISALUD), Health Research Institute, SERGAS-UVIGO, Vigo, Spain; Dermatology Department, Hospital do Meixoeiro and University of Vigo, 36200 Vigo, Spain. Electronic address:

Purpose: In this paper, we reported three distinct cases of tinea, including tenia ungulum, tenia pedis, and tenia cruris caused by the infection of Nannizzia nana in the immunocompetent patients who were also the residents of Guatemala. Dermatophytes were identified phenotypically and genotypically. Thereafter, DNA was extracted from the fungal isolates and a fragment of the ITS1-5. Read More

View Article and Full-Text PDF

A rare case of coexistence of autoimmune polyglandular syndrome type 3 with growth hormone deficiency and hyperthyroidism in a patient with pseudo-Turner's syndrome.

J Int Med Res 2020 Oct;48(10):300060520961684

Department of Emergency, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.

Autoimmune polyglandular syndrome (APS) is a rare disease that is characterized by autoimmune reactions to multiple endocrine and non-endocrine organs, which can be divided into four main types. The principal manifestations of APS-3 are autoimmune thyroid disease and other autoimmune diseases, such as type 1 diabetes, atrophic gastritis, pernicious anemia, vitiligo, alopecia, and myasthenia gravis, but not Addison's disease or hypoparathyroidism. Here we report a case demonstrating the rare coexistence of growth hormone deficiency and hyperthyroidism with sexual dysgenesis, secondary amenorrhea, cardiomegaly, splenomegaly, hypoproteinemia, pleural effusion, seroperitoneum, pericardial effusion, anasarca, osteoporosis, vitamin D deficiency, iron-deficiency anemia, poor blood coagulation, leucocytopenia, peripheral neuropathy, hyperuricemia, ichthyosis, tinea cruris, and onychomycosis. Read More

View Article and Full-Text PDF
October 2020

Terbinafine-induced lichenoid drug eruption: case report and review of terbinafine-associated cutaneous adverse events.

Dermatol Online J 2020 Jul 15;26(7). Epub 2020 Jul 15.

San Diego Family Dermatology, National City, CA, Touro University California College of Osteopathic Medicine, Vallejo, CA Scripps Family Medicine Residency, Scripps Mercy Hospital Chula Vista, Chula Vista, CA Family Medicine Residency, Family Health Centers of San Diego, San Diego, CA.

Terbinafine is an antifungal agent used in the treatment of hair, nail, and skin dermatophyte infections. Skin side effects to terbinafine are not common. Lichenoid drug eruption is a medication-related adverse cutaneous event; the lesion morphology and pathology mimic lichen planus. Read More

View Article and Full-Text PDF